[ is distinct conversations ]. And live here this morning on c spann span 3, a discussion about transparency and oversight at the food and Drug Administration. Well be hearing from dr. Scott gottlieb starting off the conference. Introductions under way. Efforts to pass and implement the food safety modernization act, focus on medical devices, especially the potential of using the unique device identifier to improve monitoring devices throughout the product lifecycle. We have successfully worked on products 10 to courage innovation particularly around antibiotics and 10 to sure appropriate use of them. We focused on drug safety and transparency in the supply chain and especially on the safety of compounded drugs. Among other things, pew submitted transparency to the task force back in 2010 if the. They touch on some of the topics well be discussing today. Reading the background papers for todays meet regular mind med of a meeting we convened in a room directly above of us here a few yea
Process to approve new drugs. This is 35 minutes. Thanks a lot. Thanks for the opportunity to be here today. We had a dialogue over many years, and i appreciate the relationship we had talking about policy issues. I wrote a subsequent article saying whats taking you so long, josh. So ive been waiting for him to return the favor, and i just got a copy of it. So i appreciate it very much. Thanks for the opportunity to be here today. Thanks john hopkins for hoestin this, and pew for providing space. Transparency can be a powerful tool for innovation. New platforms for visualizing large complex data sets present important new opportunities for the research and Development Community for regulators and for clinicians. It allows people to harness data to advance the safe and effective and Efficient Development for medical needs and to communicate information supporting regulatory Decision Making in ways that engender Greater Public confidence in those decisions. The fdas goal is to advance tr
I wrote a subsequent article saying whats taking you so long, josh. So ive been waiting for him to return the favor, and i just got a copy of it. So i appreciate it very much. Thanks for the opportunity to be here today. Thanks john hopkins for hoestin this, and pew for providing space. Transparency can be a powerful tool for innovation. New platforms for visualizing large complex data sets present important new opportunities for the research and Development Community for regulators and for clinicians. It allows people to harness data to advance the safe and effective and Efficient Development for medical needs and to communicate information supporting regulatory Decision Making in ways that engender Greater Public confidence in those decisions. The fdas goal is to advance transparency without reducing incentives to innovate. This can be accomplished by meeting our statutory responsibility for protecting confidential, commercial information, trade secrets and private data while dissemi
Negotiating objective. This is straightforward improvement in the act and makes no changes in the language that was negotiated on a bipartisan basis by the committee. The only change is the is to move it from section 2a11 to the end of section 2b. The reason relates to effective enforcement in the rule of law dwoesh dwoesh negotiating objectives. In particular, the dispute settlement objectives require ustr to seek provisions that treat the United States principal negotiating objectives yawly with respect to the availability to resort to dispute settlement under the applicable, availability of equivalent remedies. As for principle trade objective, objectives. Therefore, by moving this from overall to principle, we do get the enforcement that i have been talking about at some time. Mr. Chairman let me just make this clear and ill be glad to ask mr. White the question. We have cleared with the ustr that this amendment is consistent with their negotiations of the trans pa sifb community a
From portland, oregon. Gabe, this pan demme sick getting worse nationwide, where you are, iowa hit a record high for the number of deaths in a single day with a 41 test Positivity Rate. We hear a lo of numbers. The statistics are staggering and some doctors sound close to their breaking point. How are they coping . Reporter hey there, hallie. Youre right. 41 Positivity Rate here in iowa. The White House Coronavirus Task Force Report puts iowa and its neighboring states in the red zone throughout the country, warning of an unyielding and exponential spread of the virus. At this hospital the icu is full here, so are the icus at several other hospitals in des moines and we spoke with a doctor here who is frustrated that more people havent adhered to Public Safety guidelines, Public Health guidelines in the last few months. Take a listen to her message. I think its incredibly frustrating. I think theres a sense that no one is listening to us and it really does feel at times as if were on t